A carregar...
Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar
OBJECTIVES: The aim of the study was to determine whether it is safe to stop secondary prophylaxis in patients with talaromycosis after immune reconstitution with a sustained increase in CD4 count to ≥ 100 cells/µL after antiretroviral therapy (ART). METHODS: A retrospective cohort analysis was perf...
Na minha lista:
| Publicado no: | HIV Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590157/ https://ncbi.nlm.nih.gov/pubmed/32741092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12921 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|